Weed in Review: 2.23.18

Weed in Review: Friday, February 23, 2018

In the United States

Why legal marijuana businesses are being kicked off social media: As CNET reports, one Las Vegas dispensary’s Instagram account has been deactivated on six different occasions. When business owners requested assistance from its parent company, Facebook, the only response they received was having their account shut down again.

Top cannabis regulator: Massachusetts should consider government-run bank for pot companies: Massachusetts should consider creating a state-run bank to serve recreational marijuana companies, the state’s top cannabis official suggested Wednesday, warning that an all-cash industry would create security risks and regulatory headaches.

California’s real impact on the battle to legalize marijuana: California’s legalization of cannabis for recreational use could have an outsize influence on the debate nationwide. Beyond its impressive numbers, California’s largest impact on legal weed will stem from the state’s disproportionate cultural reach and its ability to shape opinion.

Lawmaker seeks pause to fix medical marijuana flaws: COLUMBUS — A new bill would block Ohio’s award of final licenses for medical marijuana growing facilities, processors, and testers while it fixes flaws with the way it has scored applications.

Professor Rich Fulcher joins Matt Besser for the pilot episode of the new podcast, Marijuana Advice. They take listener calls about all things marijuana, from what the future of the cannabis industry looks like to the dangers of driving high to the best weed for an amazing sexual experience. Plus, they give tips on the best way to combat paranoia as well as how to get your pot brownies to kick in faster.

Alabama Appleseed Statement on Committee Hearings on Legislation to Reclassify Marijuana Possession Offenses: Today the Alabama Senate and House Judiciary Committees considered legislation to reclassify one ounce or less of marijuana as a civil offense, the possession of more than one ounce but less than two ounces as a Class D felony, and the possession of more than two ounces as a Class C felony. SB 251 (Senator Brewbaker) received a favorable report and HB 272 (Representative Todd) did not receive a favorable report.

Candy & cannabis: Hershey’s renews trademark legal disputes with marijuana businesses: Cannabis businesses, beware: The Hershey Co. is on the warpath.

7 Cannabis Edibles That Changed the Game: For starters, the quality, variety, and sophistication of what’s available has come a long way in a short time, including the emergence of trusted brands that deliver a consistently high caliber product. Savvy shoppers have also discovered that edibles represent the best psychoactive bargain at the dispensary, because when you eat cannabis—instead of smoking it—a chemical process in the liver transforms the THC found in the plant into a much more powerful and longer-lasting molecule.

Weed in Review: 2.23.2018 at Herbaceous Inc.

Medical Research Updates

Publications from Addiction: Debunking Two Claims about US Medical Marijuana: Increased Recreational Use among Teens and Decreased Opioid Deaths:

Medical marijuana laws and adolescent marijuana use in the United States: A systematic review and meta-analysis: The first claim, that legalizing medical marijuana increases recreational use among adolescents, is addressed by a new meta-analysis that pooled the results of eleven separate studies of data from four large-scale US surveys dating back as far as 1991.  Results of the meta-analysis indicate that no significant changes (increases or decreases) occurred in adolescent recreational use following enactment of medical marijuana laws.  Far fewer studies examined the effects of medical marijuana laws among adults, although existing evidence suggests that adult recreational use may increase after medical marijuana laws are passed.

Decreased Opioid Deaths (an editorial): The second claim, that legalizing medical marijuana reduces opioid overdose deaths by offering a less risky method of pain management, is addressed in an editorial co-authored by several members of Addiction’s editorial board.  Here, the evidence is clear but weak, being rooted in ecological studies whose results have not been confirmed through more rigorous methods.  Although those studies show a correlation over time between the passage of medical marijuana laws and opioid overdose death rates, they do not provide any evidence that the laws caused the reduction in deaths.  In fact, several recent studies have shown that chronic pain patients who use cannabis do not use lower doses of opioids.  There are more plausible reasons for the reduction in opioid deaths that ought to be investigated.    

Investigating causal associations between use of nicotine, alcohol, caffeine and cannabis: a two-sample bidirectional Mendelian randomization study: Two-sample Mendelian randomization analyses found little evidence for causal relationships between nicotine, alcohol, caffeine and cannabis use.

Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercial Options: Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the Company’s groundbreaking laboratory research with Dana-Farber Cancer Institute using Nanoparticle Drone technology and Cannabinoids to successfully kill cancer cells has now reached a serious level of attention. The Cannabis Science Dana-Farber research team has now begun next level planning to bring this efficacious research to full commercialization.


Thailand considering steps to become ‘medical marijuana hub’: A proposed revision to Thailand’s notoriously strict narcotics law would ultimately permit the cultivation and use of medical cannabis across the Asian country.

Will AusCann Group Become A Global Player In The Cannabis Sector?: Implications of Australia giving the go-ahead to export medical marijuana. AusCann Group is the only Australian cannabis producer with all licenses approved. Why requirement to meet domestic demand first isn’t an issue for AusCann.

Canadian Cannabis Producer With $100 Million For International Expansion: Organigram (OGI.V; OTCQB:OGRMF) is a Canadian cannabis producer, based in Moncton, New Brunswick. OGI has a current production capacity of 5,200 kg/year, rising to about 25,000 kg/year by late summer. OGI also has a fully funded expansion to increase capacity to 65,000 kg/year in 2020. The company has also recently raised $108 million to fund international expansion. Details of that international expansion have yet to be announced.



Check out Cannabis Business Times Events Page for the latest.

Our favorite news sources:

The Cannabist

High Times

Merry Jane

Vice Marijuana